{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(1)"],"submitter":["Thomas S"],"funding":["National Institute for Health Research (NIHR)","Rosetrees"],"journal":["Journal for immunotherapy of cancer"],"pagination":["214"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6689178"],"repository":["biostudies-literature"],"pubmed_title":["Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1."],"pmcid":["PMC6689178"],"funding_grant_id":["M236-F1-CD1","NF-SI-0515-10101"],"pubmed_authors":["Kaufman HL","Mansfield D","Bommareddy PK","Thomas S","Kyula JN","Smith H","Roulstone V","Kuncheria L","Harrington KJ","Coffin RS"],"additional_accession":[]},"is_claimable":false,"name":"Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Aug","modification":"2026-05-02T20:01:41.007Z","creation":"2025-02-19T01:34:46.979Z"},"accession":"S-EPMC6689178","cross_references":{"pubmed":["31399043"],"doi":["10.1186/s40425-019-0682-1"]}}